Update shared on04 Sep 2025
Analysts remain divided on EQT, with bulls highlighting strong year-to-date performance and recovery-driven upgrades, while others caution that rich valuation limits further upside, resulting in an unchanged consensus price target of SEK366.92.
Analyst Commentary
- Bullish analysts cite a constructive outlook for first half results and several potential catalysts driving further share price upside.
- Upgrades are supported by the company's strong recovery and nearly 30% share price rebound since April lows.
- Positive news flow and robust year-to-date performance are acknowledged, though some see these factors as already reflected in the valuation.
- Bullish analysts point to ongoing sector outperformance and improved business momentum as core reasons for higher targets and upgrades.
- Neutral and cautious analysts note that EQT's premium valuation relative to peers and recent strong share price performance leave limited scope for upside.
What's in the News
- EQT is a leading contender, alongside Bain Capital, for a 31% controlling stake in Whirlpool of India, with an expected transaction value of $550-600 million; due diligence is ongoing, and the winner will trigger an open offer for 26% more.
- EQT and Brookfield have been shortlisted to acquire Gland Pharma from Fosun Group in a deal potentially exceeding $3 billion, but high share prices and macro/geopolitical headwinds pose risks to completion.
- EQT is competing with CVC, Permira, and HSBC for a controlling stake in Nuvama Wealth Management, valued around $1.6 billion, with ongoing due diligence and regulatory scrutiny stemming from a market manipulation probe.
- EQT is reportedly evaluating a €5 billion bid for European fund services provider IQ-EQ, joining other major private equity firms in pre-sale deliberations.
- EQT is seeking to sell a significant minority stake in the Italian unit of Radius Global Infrastructure, with expected offers exceeding €1 billion.
Valuation Changes
Summary of Valuation Changes for EQT
- The Consensus Analyst Price Target remained effectively unchanged, at SEK366.92.
- The Future P/E for EQT has significantly risen from 24.50x to 270.27x.
- The Discount Rate for EQT remained effectively unchanged, at 6.18%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.